Nechama M - Search Results

1

Pin1-Targeted Therapy for Systemic Lupus Erythematosus.

Wei S, Yoshida N, Finn G, Kozono S, Nechama M, Kyttaris VC, Zhen Zhou X, Tsokos GC, Ping Lu K. Wei S, et al. Among authors: nechama m. Arthritis Rheumatol. 2016 Oct;68(10):2503-13. doi: 10.1002/art.39741. Arthritis Rheumatol. 2016. PMID: 27159270 Free PMC article.

2

Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease.

Chen CH, Li W, Sultana R, You MH, Kondo A, Shahpasand K, Kim BM, Luo ML, Nechama M, Lin YM, Yao Y, Lee TH, Zhou XZ, Swomley AM, Butterfield DA, Zhang Y, Lu KP. Chen CH, et al. Among authors: nechama m. Neurobiol Dis. 2015 Apr;76:13-23. doi: 10.1016/j.nbd.2014.12.027. Epub 2015 Jan 6. Neurobiol Dis. 2015. PMID: 25576397 Free PMC article.

3

Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.

Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You MH, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke NJ, Cao S, Reschke M, Chen CH, Rego EM, Lo-Coco F, Cantley LC, Lee TH, Wu H, Zhang Y, Pandolfi PP, Zhou XZ, Lu KP. Wei S, et al. Among authors: nechama m. Nat Med. 2015 May;21(5):457-66. doi: 10.1038/nm.3839. Epub 2015 Apr 13. Nat Med. 2015. PMID: 25849135 Free PMC article.

4

The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation.

Nechama M, Kwon J, Wei S, Kyi AT, Welner RS, Ben-Dov IZ, Arredouani MS, Asara JM, Chen CH, Tsai CY, Nelson KF, Kobayashi KS, Israel E, Zhou XZ, Nicholson LK, Lu KP. Nechama M, et al. Nat Commun. 2018 Apr 23;9(1):1603. doi: 10.1038/s41467-018-03886-6. Nat Commun. 2018. PMID: 29686383 Free PMC article. Clinical Trial.

5

An unusual two-step control of CPEB destruction by Pin1.

Nechama M, Lin CL, Richter JD. Nechama M, et al. Mol Cell Biol. 2013 Jan;33(1):48-58. doi: 10.1128/MCB.00904-12. Epub 2012 Oct 22. Mol Cell Biol. 2013. PMID: 23090969 Free PMC article.

6

The scavenger receptor MARCO modulates TLR-induced responses in dendritic cells.

Kissick HT, Dunn LK, Ghosh S, Nechama M, Kobzik L, Arredouani MS. Kissick HT, et al. Among authors: nechama m. PLoS One. 2014 Aug 4;9(8):e104148. doi: 10.1371/journal.pone.0104148. eCollection 2014. PLoS One. 2014. PMID: 25089703 Free PMC article.

7

Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia.

Shilo V, Ben-Dov IZ, Nechama M, Silver J, Naveh-Many T. Shilo V, et al. Among authors: nechama m. FASEB J. 2015 Sep;29(9):3964-76. doi: 10.1096/fj.15-274191. Epub 2015 Jun 8. FASEB J. 2015. PMID: 26054367

8

The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels.

Nechama M, Ben-Dov IZ, Briata P, Gherzi R, Naveh-Many T. Nechama M, et al. FASEB J. 2008 Oct;22(10):3458-68. doi: 10.1096/fj.08-107250. Epub 2008 Jun 26. FASEB J. 2008. PMID: 18583400

9

Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.

Nechama M, Ben-Dov IZ, Silver J, Naveh-Many T. Nechama M, et al. Am J Physiol Renal Physiol. 2009 Apr;296(4):F795-800. doi: 10.1152/ajprenal.90625.2008. Epub 2009 Jan 7. Am J Physiol Renal Physiol. 2009. PMID: 19129257 Free article.

10

The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism.

Nechama M, Uchida T, Mor Yosef-Levi I, Silver J, Naveh-Many T. Nechama M, et al. J Clin Invest. 2009 Oct;119(10):3102-14. doi: 10.1172/JCI39522. Epub 2009 Sep 21. J Clin Invest. 2009. PMID: 19770516 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page